The study is a quantitative randomized control trial (RCT) with a longitudinal pre-test, mid-test and post-test within and between subject design. It was conducted between July 2023 and December 2024. This study has been developed under a multicenter basis, since the intervention has involved institutionalized participants in two different nursing homes/care facilities as well as participants in community-dwelling settings. Participants were randomly allocated to two groups (experimental and control). Randomization was performed by means of a computer-generated random number schedule. The trial began with 187 participants. The objective of the intervention was to determine if after the application of a multimodal intervention for 18 months, the subjects would obtain significant improvements in the scores of different clinically validated tests
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
quality of life
Timeframe: up to 18 months
Cognitive impairment
Timeframe: up to 18 months
depression
Timeframe: up to 18 months
perceived loneliness
Timeframe: up to 18 months
Activities of daily living (ADL)
Timeframe: up to 18 months
Instrumental activities of daily living (iADL)
Timeframe: up to 18 months
Tinetti scale
Timeframe: up to 18 months